# To Assess the Drug-drug Interaction Potential Between Dapivirine Vaginal Ring-004, Containing 25 mg of Dapivirine, and Clotrimazole 10 mg/g (1%)

> **NCT02847286** · PHASE1 · COMPLETED · sponsor: **International Partnership for Microbicides, Inc.** · enrollment: 36 (actual)

## Conditions studied

- HIV- Prevention

## Interventions

- **DRUG:** Dapivirine Ring-004
- **DRUG:** Dapivirine Ring-004 for 28 days along with clotrimazole
- **DRUG:** Clotrimazole

## Key facts

- **NCT ID:** NCT02847286
- **Lead sponsor:** International Partnership for Microbicides, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-01
- **Primary completion:** 2016-11-28
- **Final completion:** 2016-11-28
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02847286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02847286, "To Assess the Drug-drug Interaction Potential Between Dapivirine Vaginal Ring-004, Containing 25 mg of Dapivirine, and Clotrimazole 10 mg/g (1%)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02847286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*